Content about Pharmaceutical industry

July 21, 2010

British drug maker GlaxoSmithKline is the latest company to join health policy research organization the...

July 21, 2010

An investigational treatment for HIV made by Johnson & Johnson subsidiary Tibotec Pharmaceuticals works as...

July 20, 2010

Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday....

DETROIT Generic drug maker Caraco Pharmaceutical Labs has launched a generic antidepressant, Caraco said Wednesday.

 

The drug maker announced the launch of bupropion hydrochloride extended-release tablets in the 150 mg and 200 mg strengths.

 

 

The drug is a generic version of GlaxoSmithKline’s Wellbutrin SR. Various versions of the drug have annual sales of $300 million, according to Caraco.

 

July 20, 2010

A Food and Drug Administration advisory committee has voted to recommend limiting use of a...

July 20, 2010

Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant,...

MORRISTOWN, N.J. Actavis has received regulatory approval from the Food and Drug Administration for a generic antidepressant, the drug maker announced Wednesday.

Actavis said it immediately will begin distributing its bupropion HCl extended-release (SR) tablets in 100-mg and 200-mg strengths. The drug is the generic equivalent of GlaxoSmithKline's Wellbutrin SR. Actavis already has marketed generic Wellbutrin SR in the 150-mg strength. The drug maker received approval in March 2008.

July 20, 2010

Pfizer is selling one of its New York properties to financial services firm TIAA-CREF, according...

July 18, 2010

The Food and Drug Administration has given priority review to an application from Amgen for...

July 18, 2010

A U.S. District Court has ruled in favor of two companies who alleged patent infringement...

July 18, 2010

RediClinic, which operates more than 20 clinics in H-E-B grocery stores in Houston and Austin,...

HOUSTON RediClinic, which operates more than 20 clinics in H-E-B grocery stores in Houston and Austin, has expanded its menu of services with the addition of prescription medications Vaniqa and Lustra.

July 18, 2010

Biotechnology company Spectrum Pharmaceuticals has appointed a new SVP, chief scientific officer and head of...

July 15, 2010

It’s been said many times that the people you know are as important as what...

WHAT IT MEANS AND WHY IT'S IMPORTANT It’s been said many times that the people you know are as important as what you know. In the case of Billy Tauzin, former president and CEO of the Pharmaceutical Research and Manufacturers of America, this adage was especially true, considering his former career as a member of Congress.

(THE NEWS: PhRMA names new president, CEO. For the full story, click here)

July 15, 2010

Rounding out its Kerr Health management team, Kerr Drug has gone beyond its own deep...

WHAT IT MEANS AND WHY IT’S IMPORTANT Rounding out its Kerr Health management team, Kerr Drug has gone beyond its own deep bench of retail-oriented players.

(THE NEWS: Domann named Kerr Health's VP sales and business. For the full story, click here)

July 15, 2010

Sales and profits grew significantly for Swiss drug maker Novartis, with significant growth across divisions,...

July 15, 2010

The Personal Care Products Council announced on July 15 that it is calling for a...

WASHINGTON The Personal Care Products Council announced on July 15 that it is calling for a greater role by the Food and Drug Administration in regulatory oversight of personal care products and assessing ingredient safety.

The announcement came less than a week before the introduction of the Safe Cosmetics Act of 2010 in Congress by Reps. Jan Schakowsky, D-Ill., Ed Markey, D-Mass., and Tammy Baldwin, D-Wis.

July 14, 2010

A joint advisory committee of the Food and Drug Administration has voted to recommend allowing...

July 14, 2010

Biotech giant Amgen has appointed a former Novartis executive to its board, Amgen said Thursday....

July 14, 2010

The Food and Drug Administration has given special designation to an investigational treatment for a...

July 14, 2010

Generic drug maker Mylan is hoping to gain entry into the injectable drug market with...

July 13, 2010

Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said....

NORTH WALES, Pa. Teva Pharmaceuticals has launched a drug for treating migraine headaches, the generic drug maker said.

 

Teva announced the launch of naratriptan tablets in the 1 mg and 2.5-mg strengths. The tablets are a generic version of GlaxoSmithKline’s Amerge. The drug is used to treat acute migraine attacks in adults with or without visual disturbances preceding the attacks known as aura.

 

 

July 12, 2010

The 5th Annual Rare Disease Leadership Summit being held Wednesday in Arlington, Va., will feature...

July 12, 2010

Generic drug maker Amneal Pharmaceuticals has appointed a former Par Pharmaceutical Cos. executive as chief...

July 12, 2010

The main lobby for the pharmaceutical industry has appointed the president and CEO of Business...

July 12, 2010

Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of...

MORRISTOWN, N.J. Generic drug maker Watson Pharmaceuticals hopes to be the first to market a version of a kidney disease treatment made by Genzyme, Watson said Monday.

Watson said it filed a regulatory approval application with the Food and Drug Administration for sevelamer carbonate for oral suspension. The drug is a generic version of Genzyme’s Renvela, used to control serum phosphorus in patients with chronic kidney disease who are on dialysis.

 

July 11, 2010

Regional retail pharmacy chain Kerr Drug has hired former GlaxoSmithKline and Johnson & Johnson executive...

July 11, 2010

Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss...

PRINCETON, N.J. Sandoz has launched a generic drug for treating migraine headaches, the generics arm of Swiss drug maker Novartis said Monday.

 

Sandoz launched naratriptan hydrochloride tablets in the 2.5-mg strength, a generic version of GlaxoSmithKline’s Amerge. The tablets are used for treating acute migraine attacks in adults with or without visual disturbances that occur before the onset of the headache, also known as aura. Studies have indicated that around 12% of Americans have migraine attacks.